Rani Therapeutics: Oral Biologics Vision Still Has Early-Stage Risks
Source: SeekingAlpha
2025-11-05 15:22:53 ET
...
Read the full article on Seeking Alpha
For further details see:
Rani Therapeutics: Oral Biologics Vision Still Has Early-Stage Risks
Chugai Pharmaceuticals Co. Ltd. ADR
NASDAQ: CHGCY
CHGCY Trading
0.43% G/L:
$30.13 Last:
59,797 Volume:
$30.02 Open:
CHGCY Latest News
CHGCY Stock Data
$96,444,219,781
3,258,139,484
N/A
8
N/A
Pharmaceuticals
Healthcare
JP
Chuo-Ku
